Drug promotion and scientific exchange

Academic Article

Abstract

  • To the Editor: In my 20-year experience working with the pharmaceutical industry, I have never been subjected to the pressures, censorship, or constraints described by Dr. Kessler (July 18 issue)* and have been given the freedom to organize symposiums, monographs and round-table discussions as I saw fit. If the unapproved use of a drug or technique entered into the discussion, it was often at the request of the participants or the host institution, or as part of a general review of a subject. In addition, since audiences are interested in the most advanced clinical research and therapy, all academicians deal. . . © 1992, Massachusetts Medical Society. All rights reserved.
  • Published In

    Digital Object Identifier (doi)

    Author List

  • Blackwell RE; Blue BA; Wilbur RS; Ozols RF; Vogel RM; Kessler DA
  • Start Page

  • 133
  • End Page

  • 134
  • Volume

  • 326
  • Issue

  • 2